Acuvue Oasys 1-Day with HydraLuxe: Daily contacts for dry, digital eyes
12.06.2026 - 17:53:03 | ad-hoc-news.de
Responsible: ad hoc news Lifestyle & Consumer Desk. Reviewed prior to publication on June 12, 2026 at 5:52 PM ET. Details in the imprint.
Acuvue Oasys 1-Day with HydraLuxe are daily disposable silicone hydrogel contact lenses from Johnson & Johnson Vision, positioned for people who want clear vision with minimal end-of-day dryness when using screens, driving, or working in air-conditioned offices. These lenses use the company’s HydraLuxe technology, which integrates tear-like molecules into the lens material to help support a stable tear film over the course of the day. In the U.S., eye care professionals often recommend the product for wearers who experience dryness with older hydrogel lenses or who prefer the hygiene and convenience of a fresh pair every day. Pricing varies by retailer, but major chains and online sellers in the U.S. typically list a 90-lens box in the range of roughly $70 to $100 before rebates, depending on prescription and promotions.
What Acuvue Oasys 1-Day with HydraLuxe are designed to do
Acuvue Oasys 1-Day with HydraLuxe are indicated for the correction of refractive errors such as myopia and hyperopia in people with healthy eyes who can wear soft contact lenses. The lenses are made from senofilcon A, a silicone hydrogel material that allows relatively high levels of oxygen to reach the cornea compared with traditional hydrogel lenses. Johnson & Johnson states that the Dk/t value (a measure of oxygen transmissibility) for Acuvue Oasys 1-Day with HydraLuxe is 121 at -3.00D, which is designed to support corneal health during daily wear when the lenses are used as directed. The water content is listed at 38 percent, a typical value for this class of silicone hydrogel daily disposable lenses.
A key differentiator is the HydraLuxe wetting technology, which Johnson & Johnson describes as a tear-infused design that uses proprietary tear-like molecules to help reduce friction and stabilize the tear film. According to product literature, this approach aims to deliver a lens surface that works with the natural tear film, especially under demanding conditions such as prolonged digital device use or exposure to dry indoor air. In practical terms, many eye care providers position these lenses for patients who complain about tired or dry eyes in the late afternoon with older two-week or monthly lenses. The manufacturer notes that the lens has a smooth front surface and optimized edge profile to support comfort during blinking.
The lenses incorporate Johnson & Johnson’s UV-blocking technology, offering what the company describes as Class 1 UV protection, which means they block more than 90 percent of UVA and more than 99 percent of UVB radiation within the stated wavelength range. While this can provide an extra layer of protection for the cornea and internal eye structures, the company and eye health organizations stress that contact lenses do not cover the entire eye and should be used together with UV-blocking sunglasses and a hat when appropriate. Acuvue Oasys 1-Day with HydraLuxe also feature a light blue handling tint and a 1-2-3 inside-out indicator to make insertion easier for new wearers. This small design detail can help reduce early handling errors and improve the initial experience for people switching from glasses to contacts.
From a wear schedule standpoint, Acuvue Oasys 1-Day with HydraLuxe are approved for daily wear only and must be discarded after a single day of use, with no overnight or extended wear. Johnson & Johnson emphasizes that the daily disposable modality can reduce the need for cleaning solutions and lens cases and may lower the risk of certain lens-related complications when combined with proper hygiene. Patients receive their specific wearing instructions from an eye care professional, and the product is only available in the U.S. by prescription following a contact lens fitting. The power range typically spans from around -12.00D for higher myopia to +8.00D for higher hyperopia in 0.25D steps in most of the commonly used range. Not all parameters are stocked by all retailers, so availability of specific prescriptions can vary.
On the U.S. market, Acuvue Oasys 1-Day with HydraLuxe sit above some entry-level daily lenses in Johnson & Johnson’s own line, reflecting their silicone hydrogel material and feature set. They are positioned as a premium daily disposable option for people who prioritize comfort and eye health features such as high oxygen transmissibility and UV blocking. For wearers with astigmatism, Johnson & Johnson manufactures a related toric version, Acuvue Oasys 1-Day for Astigmatism, which uses the same HydraLuxe technology combined with the company’s Eyelid Stabilized design to help keep the lens oriented correctly. That toric variant has its own parameter range and fitting guidance and is usually prescribed separately for patients who need cylindrical correction.
Consumer reviews and professional feedback in the U.S. are generally favorable for Acuvue Oasys 1-Day with HydraLuxe, especially among patients who have had dryness issues with older materials. Online ratings at major U.S. contact lens retailers commonly score this product above 4 out of 5 stars, with users often citing all-day comfort and clear vision as reasons for repeat purchasing. Some reviewers note that the cost per day can be higher than for two-week or monthly lenses, which may influence whether they wear them every day or reserve them for travel, sports, or long workdays. Eye care practitioners often weigh these cost considerations against potential comfort and hygiene benefits, particularly for patients who have a history of compliance problems with lens cleaning or replacement schedules.
For Johnson & Johnson, Acuvue Oasys 1-Day with HydraLuxe strengthens the company’s Acuvue franchise in the fast-growing daily disposable segment, which has been gaining share in the U.S. soft contact lens market for years. The company continues to invest in premium daily lens technologies as part of its broader vision care strategy, targeting both new contact lens wearers and patients upgrading from older modalities. Shares of Johnson & Johnson (US4781601046, ticker JNJ) traded at $237.00 on the NYSE as of the close on June 9, 2026, according to company stock information.
Acuvue Oasys 1-Day with HydraLuxe at a glance
- Product: Acuvue Oasys 1-Day with HydraLuxe
- Manufacturer: Johnson & Johnson
- Category: Lifestyle & consumer daily disposable contact lenses
- Launch date: Around 2015-2016 globally; rolled out subsequently in the U.S. daily disposable segment
- MSRP / Price: Typically around $70 to $100 per 90-lens box in the U.S., depending on retailer and promotions (as of 2026)
- Availability: Prescription-only; widely available in the U.S. via eye care practices, optical chains, online contact lens retailers, and authorized sellers
- Target audience: Daily wearers seeking premium comfort, especially those with dry eye symptoms during prolonged screen use or in air-conditioned environments
- Key feature / USP: HydraLuxe tear-infused design in a silicone hydrogel daily disposable lens with Class 1 UV blocking for all-day comfort and eye health support
More background on Johnson & Johnson Vision
Readers who follow Acuvue and Johnson & Johnson Vision products can find additional company and market context on our dedicated issuer page and the group’s own investor resources.
More Johnson & Johnson newsInvestor RelationsCheck Acuvue Oasys 1-Day with HydraLuxe on Amazon
Acuvue Oasys 1-Day with HydraLuxe is listed on Amazon - check current U.S. pricing, available box sizes, and shipping options.
Acuvue Oasys 1-Day with HydraLuxe on AmazonAffiliate disclosure: as an Amazon Associate, ad-hoc-news.de earns from qualifying purchases. The price does not change for you.
This article was created with a.i. assistance and editorially reviewed. Product information is provided without warranty; prices and availability may change at any time. Not investment advice, not a buy or sell recommendation. Trading in securities carries risks up to the total loss of capital.
